Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Relmada Therapeutics Inc. (RLMD) — CORAL GABLES, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that senior management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference being held in Boston, MA, from September 8 - 10, 2026. Wells Fargo 21st Annual Healthcare Conference DetailsFormat: One-o

Source: GlobeNewswire — read the full announcement there.

See our Relmada Therapeutics company profile for background, links, and more Relmada Therapeutics news.